www.fdanews.com/articles/130857-pfizer-drug-promising-in-midstage-psoriasis-study

Pfizer Drug Promising in Midstage Psoriasis Study

October 7, 2010

Pfizer Inc’s experimental drug tasocitinib showed promise in a mid-stage clinical trial for psoriasis, the drugmaker said on Thursday.
Finanz Nachrichten